This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Triparna Sen: Innovator in Cancer Treatment
Introduction
Triparna Sen is a notable inventor based in Jadavpur, India. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on creating effective therapeutic solutions that enhance the efficacy of existing cancer treatments.
Latest Patents
Triparna Sen holds a patent for a synergistic liposomal formulation for the treatment of cancer. This formulation comprises phosphatidylcholine, stearylamine, and anticancer drugs. The patent describes how the PC:SA cationic liposome encapsulated camptothecin (CPT) and doxorubicin (DOX) formulations exhibit enhanced synergistic anti-cancer effects. These formulations provide an improved therapeutic index compared to either the liposome or the drug alone. The cationic liposomal preparation shows anticancer effects both in vitro and in vivo, without causing adverse effects on the host.
Career Highlights
Triparna Sen is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in cancer therapeutics. His dedication to innovation in this critical field has positioned him as a key figure in the scientific community.
Collaborations
Some of his notable coworkers include Nahid Ali and Manjarika De. Their collaborative efforts contribute to the ongoing research and development in cancer treatment.
Conclusion
Triparna Sen's innovative work in developing a synergistic liposomal formulation for cancer treatment highlights his commitment to improving therapeutic outcomes for patients. His contributions are paving the way for more effective cancer therapies in the future.